Lv1
60 积分 2026-05-20 加入
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
27天前
已完结
Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
1个月前
已完结
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper
2个月前
已完结
A global, phase 1/2 study of DB-1311/BNT324 (a novel B7H3 ADC) monotherapy in patients with previously treated advanced cervical cancer or platinum-resistant recurrent ovarian cancer: Outcomes by prior treatment
3个月前
已关闭
SYS6043, a B7-H3 targeting antibody-drug conjugates in patients with advanced gynecologic cancers: A phase 1/2, first-in-human study
3个月前
已关闭
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
3个月前
已完结
SYS6043, a B7-H3 targeting antibody-drug conjugates in patients with advanced gynecologic cancers: A phase 1/2, first-in-human study
3个月前
已关闭
皖公网安备34019202002308
